trypan blue has been researched along with erucylphosphocholine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gavish, M; Kugler, W; Lakomek, M; Leschiner, S; Levin, E; Pasternak, GW; Premkumar, A; Snyder, SH; Spanier, I; Veenman, L; Weisinger, G; Weizman, A | 1 |
1 other study(ies) available for trypan blue and erucylphosphocholine
Article | Year |
---|---|
The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line.
Topics: Animals; Apoptosis; Blotting, Western; Carrier Proteins; Caspase 3; Caspases; Cell Count; Cell Line, Tumor; Clone Cells; DNA, Antisense; GABA-A Receptor Antagonists; Phosphorylcholine; Protein Processing, Post-Translational; Rats; Receptors, GABA-A; Transfection; Trypan Blue | 2005 |